Personalis to Participate at Upcoming Investor Conferences
01 2월 2024 - 6:01AM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that its management team will
participate at the following investor conferences:
- BTIG MedTech, Digital Health, Life Science & Diagnostic
Tools Conference Participating on Tuesday, February 13, 2024 at The
Cliff Lodge in Snowbird, UT
- 44th Annual Cowen Healthcare Conference Presenting on
Wednesday, March 6, 2024 at 12:50 p.m. Eastern Time at the Boston
Marriott Copley Place in Boston, MA
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest time points, enable the selection of
targeted therapies based on ultra-comprehensive genomic profiling,
and enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131261127/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media Contact: pr@personalis.com
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
